J&J Defends Blood-Clotting Powder IP From Baxter Attack
A subsidiary of Johnson & Johnson has persuaded European appellate officials to approve a narrower version of its patent for a hemostatic powder that is used to treat bleeding, despite objections...To view the full article, register now.
Already a subscriber? Click here to view full article